4551 — Torii Pharmaceutical Co Cashflow Statement
0.000.00%
- ¥122bn
- ¥79bn
- ¥60bn
- 79
- 44
- 93
- 85
Annual cashflow statement for Torii Pharmaceutical Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | — | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 4,225 | 4,767 | 5,722 | 5,593 | 6,725 |
Depreciation | |||||
Non-Cash Items | 470 | -232 | -312 | -365 | 3 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -8,721 | -5,105 | -3,444 | -8,811 | -3,497 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -3,444 | -157 | 2,420 | -3,124 | 3,639 |
Capital Expenditures | -411 | -374 | -281 | -216 | -180 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 8,036 | -1,124 | -13,395 | -3,563 | -3,391 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 7,625 | -1,498 | -13,676 | -3,779 | -3,571 |
Financing Cash Flow Items | -1 | — | -2 | -2 | -1 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1,425 | -1,546 | -1,698 | -3,835 | -3,944 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2,756 | -3,201 | -12,954 | -10,738 | -3,876 |